BlueChew
BlueChew is a Chicago-based direct-to-consumer telehealth platform, founded in 2018, that provides US adult men with online consultations and compounded chewable/sublingual erectile dysfunction medications on a recurring monthly subscription of $20-$90.
- Company typePrivate
- Founded2018
- HeadquartersChicago, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What BlueChew does
BlueChew, operated by Dermacare LLC and founded in 2018, is a direct-to-consumer telehealth platform based in Chicago that connects US adult men with licensed healthcare providers for evaluation and prescription of erectile dysfunction (ED) medications in chewable and sublingual formats. The core product portfolio spans single-API chewables (Sildenafil, Tadalafil, Vardenafil), a dual-action combo (BLUE MAX combining sildenafil and tadalafil), a premium 4-in-1 sublingual flagship (BLUE GOLD, adding oxytocin and apomorphine), and adjacent wellness SKUs (DailyTAD, BLUE ENERGY). Medications are compounded by three partner state-licensed US pharmacies (Meds Pharmacy, National Treatment Delivery and Care, Curexa) and prescribed through five multi-state telehealth medical groups (Delaware, Kansas, Florida, New Jersey, California). Customers complete an online medical profile, receive provider review typically within 24 hours, and have prescriptions shipped discreetly, with service unavailable to North Dakota residents.
The business runs on a recurring monthly subscription at $20-$90/month, materially below the $300-$500/month cost of traditional ED prescriptions, with automatic renewal and bundled provider plus pharmacy fees. Go-to-market is a multi-channel D2C acquisition engine built on social media (Facebook, Instagram, TikTok, Snapchat, X), SEO and content marketing, podcast advertising, large TV campaigns, and cultural partnerships including a 2024 Anti Social Social Club fashion collaboration. The company markets itself as LegitScript Certified, has featured on NBC/ESPN/FOX/GOLF/ABC, and reports serving over 5 million men cumulatively.
The operating model is fully digital with no public funding, M&A, or revenue disclosures; ownership remains private and founder-led (co-founders Alex Jovanovich, Chief Medical Officer, and Stephen Sullivan). Geographic reach is national within the US minus North Dakota, and the product surface is intentionally narrow (men's sexual health), with the 2024-2025 product launches and marketing expansion signaling an effort to broaden into daily-use and wellness adjacencies while reinforcing the subscription economics.
BlueChew firmographics
Firmographics- Name
- BlueChew
- Legal name
- Dermacare LLC
- Website
- https://bluechew.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- BlueChew is a Chicago-based direct-to-consumer telehealth platform, founded in 2018, that provides US adult men with online consultations and compounded chewable/sublingual erectile dysfunction medications on a recurring monthly subscription of $20-$90.
- Ownership category
- akta.pro rank
BlueChew industry classification
Industry- Product category
- Men's telehealth / erectile dysfunction treatment
- NAICS
- Offices of Other Health Practitioners (6213), Offices of Physicians (6211)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Men’s Health Prescribing + Pharmacy Delivery Platforms (HLALAIAJ)
- akta.pro secondary industry
- DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription) (HLALAIAA)
Keywords
Where BlueChew is headquartered
LocationHeadquarters
- HQ city
- Chicago
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
BlueChew business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Marketing or Sales, Personnel, Supply Chain, Operations, Technology or R&D
Revenue model
- Subscription Medication Sales: BlueChew operates on a recurring monthly subscription model where customers pay for their elected subscription plan which includes automated shipment of refills and treatments. The subscription renews monthly with automatic charges to the customer's payment account. Payments include fees for healthcare provider services and pharmacy services.
- Direct Consumer Sales: Direct-to-consumer sales of compounded ED medications through the company's website. Monthly costs range from $20-90 depending on the product selected.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | BlueChew subscription plans offer monthly medication delivery with pricing between $20-90 per month |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels7 records
BlueChew product offering
Product offeringCore offering
BlueChew is a direct-to-consumer telehealth platform that connects patients with licensed medical providers for the prescription and delivery of compounded chewable and sublingual erectile dysfunction medications. Its product portfolio includes single-ingredient tablets (sildenafil, tadalafil, vardenafil), combination tablets (MAX and the 4-in-1 GOLD formula), and add-ons like DailyTAD and BlueChew ENERGY, all delivered monthly via subscription following an online medical consultation.
Product overview
BlueChew is a subscription-based telehealth platform offering chewable erectile dysfunction medications. The core product portfolio includes multiple ED treatments: BlueChew GOLD (4-in-1 premium sublingual combo with sildenafil, tadalafil, oxytocin, and apomorphine), BlueChew MAX (sildenafil + tadalafil dual-action), and single-ingredient options (TAD/tadalafil, SIL/sildenafil, VAR/vardenafil). Add-on products include DailyTAD (daily tadalafil with vitamins) and BlueChew ENERGY (sexual enhancement energy shot). All products are compounded by licensed US pharmacies and delivered discreetly to customers following online medical consultations.
Differentiator
Problem solved
Functional benefit
Products and services
- BlueChew GOLD Premium 4-in-1 sublingual tablet combining sildenafil, tadalafil, oxytocin, and apomorphine for erectile dysfunction treatment. Dissolves under the tongue and claims up to 3x stronger effects, 5x faster onset, and 8x longer duration compared to standard treatments. Marketed to adult US men seeking a stronger combination ED therapy.
- BlueChew MAX Dual-action ED medication combining sildenafil (fast-acting) and tadalafil (long-lasting) in a chewable tablet format. Designed for adult men seeking both rapid onset and extended duration of effect in a single dose.
- BlueChew TAD (Tadalafil) Single-ingredient tadalafil chewable tablet for erectile dysfunction. Uses sublingual absorption to provide long-lasting effects up to 36 hours, prescribed via online telemedicine consultation.
- BlueChew SIL (Sildenafil) Single-ingredient sildenafil chewable tablet for erectile dysfunction, containing the FDA-approved active ingredient in a fast-acting chewable format.
- BlueChew VAR (Vardenafil) Single-ingredient vardenafil chewable tablet for erectile dysfunction. Another FDA-approved PDE5 inhibitor option delivered in chewable form via the BlueChew telemedicine platform.
- DailyTAD Daily tadalafil tablet combined with seven essential vitamins in a fruit-punch chew format. Designed for ongoing daily use with no timing stress, providing consistent erectile support and additional wellness benefits.
- BlueChew ENERGY Sexual enhancement energy shot designed to boost energy and support sexual performance, sold as an add-on to the core ED medication subscription.
- BlueChew telemedicine consultation Online medical consultation and provider review service that screens customers and issues prescriptions for BlueChew ED medications, typically completed within 24 hours via the BlueChew website or mobile app.
Quantifiable outcome
- 70-85% clinical effectiveness rates comparable to brand-name alternatives
- +4 more outcomes
Companies that use BlueChew
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles1 record
BlueChew technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration12 records
Feature4 records
BlueChew partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered minor and core.
- Anti Social Social ClubminorFashion-pharma fusion collaboration resulting in a limited edition collection that merged BlueChew branding with Anti Social Social Club's streetwear aesthetic, creating merchandise and brand awareness among younger demographics.
- Your Mom's House Podcast (Christina P. and Tom Segura)minorPodcast advertising partnership featuring BlueChew ads on the Your Mom's House show, a comedy podcast hosted by Christina P. and Tom Segura, targeting the company's demographic of millennial and Gen Z men interested in men's health and comedy content.
- Delaware Telehealth Medical Group, P.A.coreLicensed healthcare provider group that delivers telehealth medical services to BlueChew patients in Delaware and other jurisdictions through the platform.
- Kansas Telehealth Medical Group, P.A.coreLicensed healthcare provider group delivering telehealth medical services to BlueChew patients through the telemedicine platform.
- Florida Telehealth Medical Group, P.A.coreLicensed healthcare provider group delivering telehealth medical services to BlueChew patients through the telemedicine platform.
- New Jersey Telehealth Medical Group, P.A.coreLicensed healthcare provider group delivering telehealth medical services to BlueChew patients through the telemedicine platform.
- California Telehealth Medical Group, P.C.coreLicensed healthcare provider group delivering telehealth medical services to BlueChew patients through the telemedicine platform.
- Meds Pharmacy, LLCcoreState-licensed compounding pharmacy that prepares and dispenses compounded ED medications to BlueChew customers after prescription approval from healthcare providers.
- National Treatment Delivery and Care LLCcorePharmacy partner handling prescription fulfillment and delivery services for BlueChew customers.
- Curexa Pharmacy LLCcoreState-licensed compounding pharmacy partner that prepares and dispenses compounded medications to BlueChew patients.
Scale indicators3 records
Recent moves6 records
Expansion highlights4 records
BlueChew competitors and assessment
Company assessmentDirect peers
- Hims & Hers Health: Public DTC telehealth platform offering ED treatments, hair loss, mental health, and primary care via subscription. Directly comparable to BlueChew's subscription telehealth + pharmacy model for men's sexual health.
- Ro: Direct-to-consumer telehealth company operating Roman (men's health/ED), Rory (women's health), and a pharmacy fulfillment arm. Closest direct competitor to BlueChew in online ED prescribing and subscription delivery.
- Lemonaid Health: Online telehealth platform prescribing ED and other common-condition medications with home delivery. Comparable DTC model, smaller scale, similar cash-pay subscription approach.
- Strut Health: Online telehealth and compounding pharmacy offering ED, hair loss, and skincare treatments via subscription. Comparable compounding-pharmacy-backed DTC telehealth model targeting men's health.
Emerging players
- Keeps: DTC men's telehealth brand focused on hair loss, now part of Thirty Madison. Comparable in men's health subscription telehealth, though focused on a different condition rather than ED.
- K Health: DTC telehealth platform offering affordable virtual primary care and ED treatment. Comparable online consultation + prescription model, though primary-care-led rather than ED-led.
- Sesame: Cash-pay online care marketplace connecting patients with providers for ED, primary care, and specialty visits. Comparable direct-pay telehealth channel with pharmacy fulfillment.
- Alpha Medical: Online primary care platform for women offering contraception, ED, and general telehealth prescriptions. Comparable telehealth + subscription prescribing model in women's and men's health.
- Marek Health: DTC men's telehealth and hormone clinic offering ED treatment, testosterone optimization, and performance medicine via subscription. Comparable men's health prescribing + pharmacy delivery focus.
Broad incumbents
- GoodRx: Public consumer-facing pharmacy platform offering discounted prescriptions including ED medications, plus telehealth. Comparable cash-pay pharmacy distribution model with significantly broader scope.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
BlueChew social profiles
Digital presenceBlueChew compliance and trust
Trust signalCompliance7 records
BlueChew financial estimates
Financial estimateRevenue estimate
Valuation estimate
BlueChew leadership team
Management profileNumber of profiles
Profiles2 records
BlueChew funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BlueChew M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BlueChew
What does BlueChew do?
BlueChew is a direct-to-consumer telehealth platform that connects patients with licensed medical providers for the prescription and delivery of compounded chewable and sublingual erectile dysfunction medications. Its product portfolio includes single-ingredient tablets (sildenafil, tadalafil, vardenafil), combination tablets (MAX and the 4-in-1 GOLD formula), and add-ons like DailyTAD and BlueChew ENERGY, all delivered monthly via subscription following an online medical consultation.
Is BlueChew a public or private company?
BlueChew is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was BlueChew founded?
BlueChew was founded in 2018. It employs 11 to 50 people.
Where is BlueChew based?
BlueChew is headquartered in Chicago, United States, in the North America region.
How does BlueChew make money?
Two revenue lines are on record. Subscription Medication Sales are the primary driver. The others are direct Consumer Sales.
Who are BlueChew's main competitors?
Direct peers on record are Hims & Hers Health, Ro, Lemonaid Health and Strut Health. Emerging players are Keeps, K Health, Sesame, Alpha Medical and Marek Health. GoodRx is listed as a broad incumbent.
Does BlueChew have an API?
No public API is recorded for BlueChew.
What industry is BlueChew in?
BlueChew's product category is Men's telehealth / erectile dysfunction treatment. Its primary akta.pro industry code is HLALAIAJ, Men’s Health Prescribing + Pharmacy Delivery Platforms, with a secondary code of HLALAIAA, DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription). Its NAICS code is 6213 and its SIC code is 8000.